Results 201 to 210 of about 66,703 (260)

Attenuation of Influenza a Virus into Live Vaccines Through C-End Degrons. [PDF]

Adv Sci (Weinh)
Wang P, Li L, Chen Y, Tong L, Li Z, Yu R, Shen Q, Wang Q, Hou J, Zhang Q, Si X, Wang N, Zhou D, Tian WX, Si L.   +14 more
europepmc   +1 more source

Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers. [PDF]

Front Cell Dev Biol
Saccu G, Fagoonee S.
europepmc   +1 more source

A protocol for computational design of mRNA vaccines with high functionality and specificity. [PDF]

Biol Direct
Ramadan MA, ElGohary HM, Faraag AH, Mysara M.   +3 more
europepmc   +1 more source

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology. [PDF]

Cancer Biol Ther
Liu X, Zhang H, Du R, Liu Z, Ren Y, Yang X.   +5 more
europepmc   +1 more source

Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor control. [PDF]

Mater Today Bio
Spitzer FS, Heuts J, Hos BJ, Romeijn S, Camps MGM, Ossendorp F, van der Maaden K.   +6 more
europepmc   +1 more source

Personalized and HPV cancer vaccines in head and neck squamous cell carcinoma: from concept to clinical implementation. [PDF]

Transl Oncol
Filippini DM, Le Tourneau C.
europepmc   +1 more source

Synthetic oligosaccharide vaccines

, 1985
Vliegenthart, J.F.G., Snippe, H., Willers, J.M.N., Kamerling, J.P.   +3 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Synthetic Vaccines

Scientific American, 1983
Synthetic vaccines are designed with the help of computer-graphics programs. These displays generated by Arthur J. Olson of the Research Institute of Scripps Clinic show a method whereby parts of a viral protein that are on the surface of a virus, and therefore accessible to antibodies, can be identified.
R, Arnon, M, Shapira, C O, Jacob
openaire   +4 more sources

Synthetic peptides as vaccines

Current Opinion in Immunology, 1992
The use of synthetic peptides as an alternative approach to vaccination is currently being pursued. This is particularly true for viral and parasitic diseases in which no vaccines are yet available, most notably the acquired immune deficiency syndrome.
R, Arnon, R J, Horwitz
openaire   +3 more sources